CA1155764A - Detection de l'antigene de l'hepatite non a et non b - Google Patents

Detection de l'antigene de l'hepatite non a et non b

Info

Publication number
CA1155764A
CA1155764A CA000413076A CA413076A CA1155764A CA 1155764 A CA1155764 A CA 1155764A CA 000413076 A CA000413076 A CA 000413076A CA 413076 A CA413076 A CA 413076A CA 1155764 A CA1155764 A CA 1155764A
Authority
CA
Canada
Prior art keywords
antigen
hepatitis
vaccine
immunologically
whenever prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000413076A
Other languages
English (en)
Inventor
Robert J. Gerety
Edward Tabor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/040,921 external-priority patent/US4356164A/en
Application filed by US Department of Commerce filed Critical US Department of Commerce
Priority to CA000413076A priority Critical patent/CA1155764A/fr
Application granted granted Critical
Publication of CA1155764A publication Critical patent/CA1155764A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA000413076A 1979-05-21 1982-10-07 Detection de l'antigene de l'hepatite non a et non b Expired CA1155764A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000413076A CA1155764A (fr) 1979-05-21 1982-10-07 Detection de l'antigene de l'hepatite non a et non b

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40,921 1979-05-21
US06/040,921 US4356164A (en) 1979-05-21 1979-05-21 Detection of non-A, non-B hepatitis associated antigen
CA000352378A CA1147647A (fr) 1979-05-21 1980-05-21 Detection des antigenes de l'hepatite contre le virus a et le virus b
CA000413076A CA1155764A (fr) 1979-05-21 1982-10-07 Detection de l'antigene de l'hepatite non a et non b

Publications (1)

Publication Number Publication Date
CA1155764A true CA1155764A (fr) 1983-10-25

Family

ID=27166688

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000413076A Expired CA1155764A (fr) 1979-05-21 1982-10-07 Detection de l'antigene de l'hepatite non a et non b

Country Status (1)

Country Link
CA (1) CA1155764A (fr)

Similar Documents

Publication Publication Date Title
CA1147647A (fr) Detection des antigenes de l'hepatite contre le virus a et le virus b
EP0061974B1 (fr) Vaccin, traitement thérapeutique de l'hépatite virale non-A non-B et procédé de préparation
Prince An antigen detected in the blood during the incubation period of serum hepatitis.
US4395395A (en) Detection of non-A, non-B hepatitis associated antigen
Neuberger et al. Immune mechanisms in tienilic acid associated hepatotoxicity.
Raizman et al. Detection of circulating antigen in acute experimental infections with Toxoplasma gondii
Pierce et al. Immunity to experimental cholera: I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization
Nepom et al. Purification and partial characterization of a tumor-specific blocking factor from sera of mice with growing chemically induced sarcomas
Myers et al. Recurrent acute hepatitis following the use of factor VIII concentrates
Dolovich et al. Antibodies of nasal and parotid secretions of ragweed-allergic subjects
Williams JR et al. IgG antilymphocyte antibodies in SLE detected by 125I protein A
CA1155764A (fr) Detection de l'antigene de l'hepatite non a et non b
Stephan et al. Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen
Ginsberg et al. Antibody to Australia antigen: detection with a simple radioimmune assay, incidence in military populations, and role in the prevention of hepatitis B with gamma globulin
Miller et al. Chronic hepatitis associated with drug abuse: significance of hepatitis B virus
Yannitsiotis et al. Jaundice and hepatitis B surface antigen and antibody in Greek haemophiliacs
Quinti et al. Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C
Walker et al. Separation of various B-cell subpopulations from mouse spleen: I. Depletion of B cells by rosetting with glutaraldehyde-fixed, anti-immunoglobulin-coupled red blood cells
Prince et al. A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine
Gitnick et al. Non-A, non-B hepatitis: A prospective study of a hemodialysis outbreak with evaluation of a serologic marker in patients and staff
Duermeyer et al. An enzyme‐linked immunosorbent assay for an antigen related to non‐a, non‐b hepatitis and its antibody: Partial characterization of the antigen and chimpanzee transmission
Yuan et al. The invivo and in vitro immunogenicity and antigenic specificity of lymphoid antigen fragment-oligoribonucleopeptide conjugates
Reesink et al. Heat-inactivated HBsAg as a vaccine against hepatitis B
Kraft The liver as an “IgA pump”
Chaudhry et al. Prevalence of hepatitis B carriers and blood group frequency in voluntary blood donors

Legal Events

Date Code Title Description
MKEX Expiry